14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

Trading levels for GTHX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.78 6.38 %
R2 4.69 4.51 %
R1 4.64 3.36 %
Current price: 4.49
Support S1 4.47 -0.387 %
S2 4.42 -1.54 %
S3 4.34 -3.41 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 4.83 7.57 %
R2 4.70 4.68 %
R1 4.55 1.34 %
Current price 4.49
Support S1 4.48 -0.223%
S2 4.47 -0.445%
S3 3.73 -16.93%

GTHX Predictions History

2 years ago
Meng122579 predicted that GTHX for 2022-01-05 is going

Rank:

3 years ago
JS predicted that GTHX for 2021-04-07 is going $25.96 (3.67%)

3 years ago
JS predicted that GTHX for 2021-04-01 is going $24.37 (2.74%)

3 years ago
mkallen.229179 predicted that GTHX for 2021-04-01 is going $24.00 (-0.25%)

Rank:

3 years ago
JS predicted that GTHX for 2021-03-01 is going $22.88 (-0.82%)

3 years ago
jjsheets330 predicted that GTHX for 2021-03-01 is going $56.00 (153.39%)

3 years ago
Mikhail Tokarenko predicted that GTHX for 2021-03-01 is going

Rank:

3 years ago
JS predicted that GTHX for 2021-02-16 is going $29.65 (-4.01%)

3 years ago
Michael Overwyk predicted that GTHX for 2021-02-16 is going

Rank:

3 years ago
JS predicted that GTHX for 2020-12-31 is going $18.75 (4.22%)

Click to get the best stock tips daily for free!

About G1 Therapeutics Inc

G1 Therapeutics G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/etoposide-containing regimen or topotecan-containing regimen for extensive stage small cell lung cancer... GTHX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT